Al-Aabideen, 2005 - Google Patents
Effect of Probiotic on Motility Factors and Swarming Phenomenon of Proteus mirabilisAl-Aabideen, 2005
View PDF- Document ID
- 11419943815614813784
- Author
- Al-Aabideen R
- Publication year
External Links
Snippet
A total of 140 samples of urine were collected from patients suffering from urinary tract infections (UTI) in Al-Yarmouk and Al-Karama hospitals in Baghdad. Samples were cultured (spreading) on MacConkey agar and blood agar and incubated at 37ºC for 24 hr. Results …
- 241000588770 Proteus mirabilis 0 title abstract description 132
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Falagas et al. | Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies | |
| Beumer et al. | Campylobacter jejuni non-culturable coccoid cells | |
| CN101454440B (en) | Probiotic strain and antimicrobial peptide derived therefrom | |
| EP0760848B1 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
| KR100446482B1 (en) | Epithelial adhesive lactobacilli | |
| US6461607B1 (en) | Probiotic, lactic acid-producing bacteria and uses thereof | |
| PT1824500E (en) | Probiotic lactobacillus strains for improved vaginal health | |
| Mansour et al. | Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection (CDI) | |
| RU2580002C1 (en) | Method of producing autoprobiotic containing living bifidus bacteria and lactic acid bacilli | |
| EP3818985B1 (en) | Lactobacillus fermentum pl9 and its application | |
| KR100435505B1 (en) | Lactobacillus plantarum isolated from kimchi with inhibiting activities on helicobacter pylori | |
| KR101098946B1 (en) | A compound for feed additive comprising novel Lactobacillus salivarius G1-1 | |
| Murphy | In vivo assessment of potential probiotic Lactobacillus salivarius strains: evaluation of their establishment, persistence, and localisation in the murine gastrointestinal tract | |
| Razmgah et al. | Probiotic potential and virulence traits of Bacillus and Lactobacillus species isolated from local honey sample in Iran | |
| Conway et al. | Strategies for the isolation and characterisation of functional probiotics | |
| Al-Aabideen | Effect of Probiotic on Motility Factors and Swarming Phenomenon of Proteus mirabilis | |
| Seto et al. | Septicaemia due to Yersinia enterocolitica biotype 1 in Hong Kong | |
| KR100720025B1 (en) | Probiotic lactic acid bacteria and composition comprising the same | |
| CN114574405B (en) | Lactobacillus plantarum WKA86, application thereof in preparation of halitosis preventing and treating product and halitosis preventing and treating product | |
| Saleh Al-Dulaimi et al. | DETECTION OF SOME VIRULENCE FACTORS AND ANTIBIOTICS SUSCEPTIBILITY OF PROTEUS MIRABILIS ISOLATED FROM DIFFERENT CLINICAL SOURCES IN BAQUBA. | |
| Kadhum | Antimicrobial activity of Lactobacillus acidophilus against pathogenic Escherichia coli isolated from diarrhea patients | |
| RU2302877C2 (en) | Biological food supplement for treatment and prophylaxis of intestine infections complicated with dysbacteriosis and for enhancing nonspecific resistance of organism | |
| Adedoyin | Isolation And Characterization Of Uropathogenic Escherichia Coli In Water Closet Used By Male Students In A Tertiary Institution In Nigeria. | |
| Yasir | I certify that this thesis entitled (Effect of Saccharomyces boula, bacteria isolated from patients with diarrhea) was prepared unde my | |
| VILLARREAL JULIO Sr et al. | INHIBITORY EFFECT OF STRAINS WITH PROBIOTIC POTENTIAL ON PATHOGENIC BACTERIA CAUSING ACUTE DIARRHEA DISEASES |